Cell Signaling Technology

Product Pathways - Tyrosine Kinase / Adaptors

Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb #2243

c-erb B2/neu protein   CD340 antigen   erbB-2   HER2   herstatin   v-erb-b2 erythroblastic leukemia viral oncogene homolog 2. neuro/glioblastoma derived oncogene homolog (avian)  

No. Size Price
2243L 300 µl ( 30 western blots ) ¥9,325.00 现货查询 购买询价
2243S 100 µl ( 10 western blots ) ¥3,900.00 现货查询 购买询价
2243T 20 µl ( 2 western blots ) ¥1,500.00 现货查询 购买询价
2243 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse, Endogenous 185 Rabbit IgG
IHC-P 1:320
IHC-F 1:320

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting, IHC-P=Immunohistochemistry (Paraffin), IHC-F=Immunohistochemistry (Frozen),

Specificity / Sensitivity

Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb detects endogenous levels of ErbB2 only when phosphorylated at tyrosines 1221/1222. The antibody does not detect other activated Erb family members or other tyrosine-phosphorylated proteins.

磷酸化HER2/ErbB2 (Tyr1221/1222) (6B12) 兔单抗仅在Tyr1221/1222被磷酸化时才能检测到内源性ErbB2的存在。本抗体不与激活的ErbB家族其它成员以及其它酪氨酸位点磷酸化的蛋白发生交叉反应。

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding tyrosines 1221/1222 of human ErbB2 protein.

单克隆抗体通过用多肽免疫动物得到,该磷酸化多肽是根据人的ErbB2蛋白Tyr1221/1222附近的氨基酸序列合成的。

Western Blotting

Western Blotting

Western blot analysis of extracts from cells expressing different activated tyrosine kinase proteins, using Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb (upper) or Phospho-Tyrosine mAb (P-Tyr-100) #9411 (lower). Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb specifically detects phosphorylated HER2/ErbB2 but not other phosphorylated tyrosine kinases. Western blot法检测表达不同激活酪氨酸激酶的细胞的提取物,使用抗体为:Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb (上) 或 Phospho-Tyrosine mAb (P-Tyr-100) #9411 (下)。其中抗体Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb 特意识别磷酸化的HER2/ErbB2 但不识别其它磷酸化的激酶。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma, showing membrane localization, using Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb. 免疫组化法检测石蜡包埋的人乳腺癌组织,可见胞膜着色。使用抗体为:Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human renal adenocarcinoma, using Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb in the presence of control peptide (left) or Phospho-HER2/ErbB2 (Tyr1221/1222) Blocking Peptide #1254 (right). 免疫组化法检测石蜡包埋的人肾腺癌组织:左图,使用对照多肽;右图,使用Phospho-HER2/ErbB2 (Tyr1221/1222) Blocking Peptide #1254 。使用抗体为:Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human NCI-H358 xenograft, using Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb. 免疫组化法检测石蜡包埋的人NCI-H358细胞的异种移植物,使用抗体为:Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded SkBr3 cell pellets untreated (left) EGF-treated (right) either untreated (top) or lambda-phosphatase-treated (bottom), using Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb. 免疫组化法检测石蜡包埋的SkBr3细胞沉淀:左图,未处理;右图,EGF处理同时未经(上)或经过(下)lambda-phosphatase处理。使用抗体为:Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb。

IHC-F (frozen)

IHC-F (frozen)

Immunohistochemical analysis of frozen HCC827 xenograft, using Phospho-Her2/ErbB2 (Tyr1221/1222)(6B12) Rabbit mAb. 免疫组化法检测HCC827异种移植物的冰冻组织,使用抗体为:Phospho-HER2/ErbB2 (Tyr1221/1222) (6B12) Rabbit mAb。

Background

The ErbB2 (HER2) proto-oncogene encodes a 185 kDa transmembrane, receptor-like glycoprotein with intrinsic tyrosine kinase activity (1). While ErbB2 lacks an identified ligand, ErbB2 kinase activity can be activated in the absence of a ligand when overexpressed and through heteromeric associations with other ErbB family members (2). Amplification of the ErbB2 gene and overexpression of its product are detected in almost 40% of human breast cancers (3). Binding of the c-Cbl ubiquitin ligase to ErbB2 at Tyr1112 leads to ErbB2 poly-ubiquitination and enhances degradation of this kinase (4). ErbB2 is a key therapeutic target in the treatment of breast cancer and other carcinomas and targeting the regulation of ErbB2 degradation by the c-Cbl-regulated proteolytic pathway is one potential therapeutic strategy. Phosphorylation of the kinase domain residue Tyr877 of ErbB2 (homologous to Tyr416 of pp60c-Src) may be involved in regulating ErbB2 biological activity. The major autophosphorylation sites in ErbB2 are Tyr1248 and Tyr1221/1222; phosphorylation of these sites couples ErbB2 to the Ras-Raf-MAP kinase signal transduction pathway (1,5).

原癌基因ErbB2 (HER2)编码185kDa的受体样跨膜糖蛋白,该蛋白具有固有的酪氨酸激酶的活性 (1)。ErbB2的配体目前尚不清楚,但在高表达的ErbB2与其它ErbB家族成员形成异源二聚体时,即使缺少配体,其酶活性仍能被激活(2)。将近40%的人类乳腺癌中能够检测到ErbB2基因的扩增及其产物的过量表达。泛素连接酶c-Cbl结合在ErbB2的Tyr1112上能够导致ErbB2聚泛素化并促进其降解(4)。ErbB2是乳腺癌等多种癌肿的关键治疗靶点,通过c-Cbl介导的蛋白水解途径靶向调控ErbB2的降解是一种潜在的治疗手段。磷酸化ErbB2的激酶位点Tyr877(同源于pp60c-Src 的Tyr416)能调控ErbB2的生物活性。ErbB2的自磷酸化位点是Tyr1248和 Tyr1221/1222,这些位点的磷酸化将ErbB2与Ras-Raf-MAP激酶的信号转导途径联系起来(1,5)。

  1. Muthuswamy, S.K. et al. (1999) Mol Cell Biol 19, 6845-57.
  2. Qian, X. et al. (1994) Proc Natl Acad Sci USA 91, 1500-4.
  3. Dittadi, R. and Gion, M. (2000) J Natl Cancer Inst 92, 1443-4.
  4. Klapper, L.N. et al. (2000) Cancer Res 60, 3384-8.
  5. Kwon, Y.K. et al. (1997) J Neurosci 17, 8293-9.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Protocols

Companion Products


For Research Use Only. Not For Use In Diagnostic Procedures.

U.S. Patent No. 5,675,063.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0

该产品暂无评论!

我要参与评论 :

如要参与评论请先登录网站

还没有网站账户?去注册一下吧

Products

 

Applications